|Calculated MW||47140 Da|
|Application & Usage||The peptide is used for blocking the antibody activity of CPA1. It usually blocks the antibody activity completely in Western blot analysis by incubating the peptide with equal volume of antibody for 30-60 minutes at 37°C.|
|Other Names||Carboxypeptidase A1, 126.96.36.199, CPA1, CPA|
|Target/Specificity||Carboxypeptidase A1 (CPA1)|
|Formulation||50 µg (0.5 mg/ml) CPA1 peptide in phosphate buffered saline (PBS), pH 7.2, containing 50% glycerol, 1% BSA and 0.02% thimerosal.|
|Reconstitution & Storage||-20 °C|
|Precautions||Carboxypeptidase A1 (CPA1) Blocking Peptide is for research use only and not for use in diagnostic or therapeutic procedures.|
|Function||Carboxypeptidase that catalyzes the release of a C- terminal amino acid, but has little or no action with -Asp, -Glu, -Arg, -Lys or -Pro.|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
If you have any additional inquiries please email technical services at email@example.com.